Internal Server Error

Oncosem - About the company

Oncosem is an unfunded company based in Cankaya (Turkey), founded in 2008. It operates as a Manufacturer of chemotherapy medication preparation systems and oncology medical devices. Oncosem has not raised any funding yet. The company has 27 active competitors, including 9 funded and 4 that have exited. Its top competitors include companies like TriSalus Life Sciences, Delcath and Luminate Medical.

Company Details

Manufacturer of chemotherapy medication preparation systems and oncology medical devices. The business produces equipment for the delivery of intravenous medication, connectors, and medical waste management tools. These products support the administration and preparation of oncology treatments within clinical environments. Secondary offerings include infusion pump components and medical grade semi-finished products used in oncology therapy workflows.
Social
Facebook
Key Metrics
Founded Year
2008
Location
Cankaya, Turkey
Stage
Unfunded
Ranked
30th among 35 competitors
Similar Companies
Sign up to download Oncosem's company profile

Oncosem's funding and investors

Oncosem has not raised any funding rounds yet.

chrome_extension_cta_illustration
Access Tracxn on any website
Our Google Chrome extension lets you view company details while browsing their websites
Install Tracxn Extension

Oncosem's Competitors and alternates

Top competitors of Oncosem include TriSalus Life Sciences, Delcath and Luminate Medical. Here is the list of Top 10 competitors of Oncosem, ranked by Tracxn score:
Rank
Company Details
Short Description
Total Funding
Investors
Tracxn Score
1st
Logo for TriSalus Life Sciences
TriSalus Life Sciences
2009, Westminster (United States), Public
Developer of drug delivery devices to treat cancers
$83.4M
66/100
2nd
Logo for Delcath
Delcath
1987, New York City (United States), Public
Speciality Pharmaceutical and medical device company focused on oncology
-
61/100
3rd
Logo for Luminate Medical
Luminate Medical
2019, Galway (Ireland), Series A
Developer of a medical device to prevent hair loss during chemotherapy
$50M
57/100
4th
Logo for Embolx
Embolx
2013, Sunnyvale (United States), Seed
Innovating arterial embolization with advanced microcatheter technology for targeted therapies
$500K
49/100
5th
Developer of a medical device used for chemotherapy
$8M
39/100
6th
Logo for Spirea
Spirea
2016, Harrogate (United Kingdom), Seed
Developer of therapeutic solutions for cancer treatments
$2.93M
39/100
7th
Logo for Encapsulate
Encapsulate
2019, Farmington (United States), Seed
Manufacturer of microfluidic-based tumour on chip technology
$1.8M
38/100
8th
Logo for AcuityBio
AcuityBio
2008, Brookline (United States), Seed
A surgical implant that prevents post-surgical lung cancer recurrence
$2.62M
37/100
9th
Logo for Cognos Therapeutics
Cognos Therapeutics
2015, Los Angeles (United States), Series B
Provider of an implantable device designed to deliver therapeutic drugs
$6M
-
36/100
10th
Logo for Current Surgical
Current Surgical
2019, Washington, DC (United States), Seed
Developer of micro-invasive therapies for the treatment of solid tumors
$4M
31/100
30th
Logo for Oncosem
Oncosem
2008, Cankaya (Turkey), Unfunded
Manufacturer of chemotherapy medication preparation systems and oncology medical devices
-
-
16/100
lockGet insights and benchmarks for competitors of 2M+ companies! Sign up today!
Looking for more details on Oncosem's competitors? Click here to see the top ones

Oncosem's Investments and acquisitions

Oncosem has made no investments or acquisitions yet.

Reports related to Oncosem

Here is the latest report on Oncosem's sector:

FAQs about Oncosem

Explore our recently published companies
Tracxn powers 1,000+ customers across 30+ countries
Accel PartnersPartechIN-Q-TEL - USFujitsuTenityStanford